register

News & Trends - Medical Technology

Johnson & Johnson breaking down barriers to gender equality

Health Industry Hub | February 26, 2021 |
[Total: 1    Average: 5/5]

MedTech News: The Johnson & Johnson Family of Companies in Australia is pleased to announce that the company has been granted the Employer of Choice for Gender Equality (EOCGE) citation in 2020-22 by the Workplace Gender Equality Agency (WGEA).

“We’re excited to have been granted the Employer of Choice for Gender Equality citation by the Workplace Gender Equality Agency. We’re proud of our extensive programs, initiatives and policies that support all of our employees be at their best in all aspects of their lives – from our focus on hybrid ways of working to ensuring equal opportunity in compensation, hiring, development and advancement,” said Charmaine England, Managing Director, Johnson & Johnson Consumer Health, Australia & New Zealand.

“We believe that fostering a culture of diversity, equity and inclusion, where everyone is treated equally must be intentional. Our workplace must represent the society in which we work and operate in relation to age, gender, race, religion, sexual preference, disability and nationality. Doing this will lead to more robust dialogue, smarter decisions and ultimately, sustainable growth in the short and long term,” said Charmaine England.

According to WGEA Director, Libby Lyons, it is this type of commitment to gender equity that led to the Johnson & Johnson Family of Companies in Australia receiving its EOCGE citation in 2020-22.

“This year, we are welcoming 17 new EOCGE citation holders who are joining the existing 119 citation holders from 2019-20. Despite the tremendous upheaval and disruption caused to Australian businesses by the COVID-19 pandemic, these dedicated organisations maintained an unswerving commitment to achieving their EOCGE citation.”

“I want to sincerely thank and acknowledge these employers for their extraordinary efforts in these trying times. We know that gender equity is good for business and crucial to our post-COVID-19 economic recovery. By driving better gender equity outcomes in their workplaces, these EOCGE citation holders are showing the right way forward for other Australian businesses,” said Ms Lyons.

As the Asia-Pacific leader of Johnson & Johnson’s Women’s Leadership and Inclusion Employee Network, Charmaine England collaborates with country leaders to not only grow awareness but to advocate for real change and inclusion of women in leadership

“We are proud to be setting the benchmark for other Australian workplaces to follow and we remain committed to in our organisation across both Australia and New Zealand,” said Charmaine England.

The Johnson & Johnson Family of Companies in Australia and New Zealand is helping to drive positive change for gender equality in the local business and broader healthcare sector. Some of the company’s initiatives to support gender equity include:

  • A Parental Leave policy supporting 14 weeks paid leave for birth mothers, 8 weeks paid Bonding Leave for partners and 8 weeks paid Adoption Leave for adoptive parents.
  • Supporting employees experiencing domestic and family violence, with access to paid leave.
  • Flexible hybrid ways of working, coupled with extensive leave options.
  • Ensuring equal opportunity in compensation, hiring, development, and advancement.
  • Reinforcing gender equity during hiring and development to attract and retain diverse talent.
  • Building inclusive leadership competencies.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - The power of being an authentic leader

The power of being an authentic leader

Health Industry Hub | April 21, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]

More


Digital & Innovation

Healthcare Technology Digital Innovations - Data is the biggest challenge, and opportunity, for MedTech

Data is the biggest challenge, and opportunity, for MedTech

Health Industry Hub | April 21, 2021 |

Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]

More


News & Trends - Medical Technology

MedTech News - Thermo Fisher acquisition to better serve its pharma and biotech clients

Thermo Fisher acquisition to better serve its pharma and biotech clients

Health Industry Hub | April 21, 2021 |

MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]

More


News & Trends - Pharmaceuticals

Pharma News - First-in-class oncology drug candidate licensed by Aussie pharma

First-in-class oncology drug candidate licensed by Aussie pharma

Health Industry Hub | April 21, 2021 |

Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]

More